CANF

Can-Fite BioPharma

9 hedge funds and large institutions have $1.9M invested in Can-Fite BioPharma in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 5 closing their positions.

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
TAM
1
Taylor Asset Management
Ontario, Canada
$1.61M 630,500 +77,400 +14%
MC
2
Menta Capital
California
$116K 45,489 +7,389 +19%
VKH
3
Virtu KCG Holdings
New York
$70K 27,573 +11,967 +77%
ARTA
4
A.R.T. Advisors
New York
$41K 16,238 +3,545 +28%
IA
5
IFP Advisors
Florida
$23K 8,900 +8,900 New
UBS Group
6
UBS Group
Switzerland
$16K 6,080 +6,080 New
Morgan Stanley
7
Morgan Stanley
New York
$14K 5,570 +5,570 New
PCM
8
Prelude Capital Management
New York
$7K 2,800 +2,800 New
Group One Trading
9
Group One Trading
Illinois
$5K 2,048
Jane Street
10
Jane Street
New York
-10,591 Closed
MFS
11
MSI Financial Services
Massachusetts
-1,000 Closed
TRCT
12
Tower Research Capital (TRC)
New York
-200 Closed
Citigroup
13
Citigroup
New York
-147 Closed
Walleye Trading
14
Walleye Trading
New York
-23 Closed